Japan Diagnostic Enzymes Market Size & Outlook, 2026-2033
- Clinical Diagnostics
- Reagents & Assays
- Diagnostic Enzymes Market Outlook
- Reagents & Assays
Global Market
Related Markets
Ask a question about the diagnostic enzymes market
Japan diagnostic enzymes market highlights
- The Japan diagnostic enzymes market generated a revenue of USD 281.4 million in 2025 and is expected to reach USD 577.5 million by 2033.
- The Japan market is expected to grow at a CAGR of 9.5% from 2026 to 2033.
- In terms of segment, glucose oxidase/glucose dehydrogenase was the largest revenue generating type in 2025.
- Lactate dehydrogenase is the most lucrative type segment registering the fastest growth during the forecast period.
Diagnostic enzymes market data book summary
| Market revenue in 2025 | USD 281.4 million |
| Market revenue in 2033 | USD 577.5 million |
| Growth rate | 9.5% (CAGR from 2026 to 2033) |
| Largest segment | Glucose oxidase/glucose dehydrogenase |
| Fastest growing segment | Lactate dehydrogenase |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Taq polymerase, MMLV RT, HIV RT, Hot start Taq pol, UNG, RNase inhibitor, Bst polymerase (LAMP enzyme), PCR Master Mix, Lyophilised Polymerase, T7 RNA polymerase, Cas9 enzyme, Acid phosphatase, Alanine aminotransferase, Alkaline phosphatase, Amylase, Angiotensin converting enzyme, Aspartate aminotransferase, Cholinesterase, Creatinine kinase, Gamma glutamyl transferase, Lactate dehydrogenase, Renin, Glucose oxidase/glucose dehydrogenase, Urease, Lactate oxidase, Horseradish peroxidase, Glutamate oxidase |
| Key market players worldwide | Takara Bio Inc, Promega, Enzo Biochem Inc, Merck KGaA, Thermo Fisher Scientific Inc, Roche, Roche Holding AG ADR, Solis BioDyne, Ampliqon, Yashraj Biotechnology |
Other key industry trends
- In terms of revenue, Japan accounted for 5.1% of the global diagnostic enzymes market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China diagnostic enzymes market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 377.9 million by 2033.
According to the National Cancer Center of Japan, in 2022, Japan reported approximately 1,019,000 new cancer cases and 380,400 cancer deaths. The most common cancers include colorectal, stomach, lung, prostate, and female breast cancers, which together accounted for about 60% of all cases.
By 2050, cancer prevalence in Japan is expected to reach around 3.67 million cases, reflecting an increase of 13.1% from 2020 levels. Surge in enzyme-based tumor marker tests (e.g., PSA for prostate cancer, CEA for colorectal cancer) supporting Japan’s robust enzyme-based diagnostics market. Companies like Sysmex and Fujirebio are pioneering high-sensitivity enzyme immunoassays for neurological and oncological biomarkers.
No credit card required*
Publish Date: Sep 18, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diagnostic Enzymes Market Scope
Diagnostic Enzymes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | www.roche.com |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | www.promega.com/es |
| Enzo Biochem Inc | View profile | 190 | 527 Madison Avenue, New York, NY, United States, 10022 | www.enzo.com |
| Solis BioDyne | View profile | 51-100 | Tartu, Tartumaa, Estonia, Europe | solisbiodyne.com |
| Ampliqon | View profile | 11-50 | Odense, Syddanmark, Denmark, Europe | www.ampliqon.com |
| Yashraj Biotechnology | View profile | 251-500 | Mumbai, Maharashtra, India, Asia | www.yashraj.com |
Japan Diagnostic Enzymes Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Diagnostic Enzymes Market Outlook will help companies and investors design strategic landscapes.
Glucose Oxidase/Glucose Dehydrogenase was the largest segment with a revenue share of 9.35% in 2025.
Horizon Databook has segmented the Japan diagnostic enzymes market based on taq polymerase, mmlv rt, hiv rt, hot start taq pol, ung, rnase inhibitor, bst polymerase (lamp enzyme), pcr master mix, lyophilised polymerase, t7 rna polymerase, cas9 enzyme, acid phosphatase, alanine aminotransferase, alkaline phosphatase, amylase, angiotensin converting enzyme, aspartate aminotransferase, cholinesterase, creatinine kinase, gamma glutamyl transferase, lactate dehydrogenase, renin, glucose oxidase/glucose dehydrogenase, urease, lactate oxidase, horseradish peroxidase, glutamate oxidase covering the revenue growth of each sub-segment from 2021 to 2033.
According to the National Cancer Center of Japan, in 2022, Japan reported approximately 1,019,000 new cancer cases and 380,400 cancer deaths. The most common cancers include colorectal, stomach, lung, prostate, and female breast cancers, which together accounted for about 60% of all cases.
By 2050, cancer prevalence in Japan is expected to reach around 3.67 million cases, reflecting an increase of 13.1% from 2020 levels. Surge in enzyme-based tumor marker tests (e.g., PSA for prostate cancer, CEA for colorectal cancer) supporting Japan’s robust enzyme-based diagnostics market. Companies like Sysmex and Fujirebio are pioneering high-sensitivity enzyme immunoassays for neurological and oncological biomarkers.
- Japan Diagnostic Enzymes Market Type Outlook (Revenue, USD Million , 2021-2033)
- UNG
- RNase inhibitor
- PCR Master Mix
- Acid phosphatase
- Alanine aminotransferase
- Angiotensin converting enzyme
- Gamma glutamyl transferase
- Renin
- Taq polymerase
- MMLV RT
- T7 RNA polymerase
- Cas9 enzyme
- Alkaline phosphatase
- Lactate dehydrogenase
- Glutamate oxidase
- HIV RT
- Hot start Taq pol
- Lyophilised Polymerase
- Glucose oxidase/glucose dehydrogenase
- Others
- Bst polymerase (LAMP enzyme)
- Amylase
- Aspartate aminotransferase
- Cholinesterase
- Creatinine kinase
- Urease
- Lactate oxidase
- Horseradish peroxidase
- Japan Diagnostic Enzymes Market Application Outlook (Revenue, USD Million , 2021-2033)
- Diabetes
- Oncology
- Infectious Diseases
- Autoimmune Diseases
- Others
- Cardiology
- Nephrology
- Japan Diagnostic Enzymes Market Product Outlook (Revenue, USD Million , 2021-2033)
- Molecular Enzymes
- Clinical Enzymes
- Japan Diagnostic Enzymes Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Clinical Laboratories
- Other End Users
Reasons to subscribe to Diagnostic Enzymes Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Diagnostic Enzymes Market Outlook databook
- Our clientele includes a mix of Diagnostic Enzymes Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Diagnostic Enzymes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Diagnostic Enzymes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Diagnostic Enzymes Market, 2021-2033 (US$M)
Japan diagnostic enzymes market statistics, by type, 2021-2033 (US$M)
